Department of Nursing and Physical Therapy, University of Almería (UAL), Spain.
Clin Rehabil. 2011 Sep;25(9):800-13. doi: 10.1177/0269215511399476. Epub 2011 Jun 14.
To determine the effect of myofascial release techniques on pain symptoms, postural stability and physical function in fibromyalgia syndrome.
A randomized, placebo-controlled trial was undertaken.
Eighty-six patients with fibromyalgia syndrome were randomly assigned to an experimental group and a placebo group.
Patients received treatments for 20 weeks. The experimental group underwent 10 myofascial release modalities and the placebo group received sham short-wave and ultrasound electrotherapy.
Outcome variables were number of tender points, pain, postural stability, physical function, clinical severity and global clinical assessment of improvement. Outcome measures were assessed before and immediately after, at six months and one year after the last session of the corresponding intervention.
After 20 weeks of myofascial therapy, the experimental group showed a significant improvement (P < 0.05) in painful tender points, McGill Pain Score (20.6 ± 6.3, P < 0.032), physical function (56.10 ± 17.3, P < 0.029), and clinical severity (5.08 ± 1.03, P < 0.039). At six months post intervention, the experimental group had a significantly lower mean number of painful points, pain score (8.25 ± 1.13, P < 0.048), physical function (58.60 ± 16.30, P < 0.049) and clinical severity (5.28 ± 0.97, P < 0.043). At one year post intervention, the only significant improvements were in painful points at second left rib and left gluteal muscle, affective dimension, number of days feeling good and clinical severity.
The results suggest that myofascial release techniques can be a complementary therapy for pain symptoms, physical function and clinical severity but do not improve postural stability in patients with fibromyalgia syndrome.
确定肌筋膜松解技术对纤维肌痛综合征疼痛症状、姿势稳定性和身体功能的影响。
进行了一项随机、安慰剂对照试验。
86 例纤维肌痛综合征患者被随机分配到实验组和安慰剂组。
患者接受治疗 20 周。实验组接受 10 种肌筋膜松解方法,安慰剂组接受假短波和超声电疗。
结局变量为压痛点数、疼痛、姿势稳定性、身体功能、临床严重程度和整体临床改善评估。在相应干预措施的最后一次治疗前后、6 个月和 1 年后评估了结局指标。
经过 20 周的肌筋膜治疗,实验组在疼痛压痛点(20.6 ± 6.3,P < 0.032)、麦吉尔疼痛评分(20.6 ± 6.3,P < 0.032)、身体功能(56.10 ± 17.3,P < 0.029)和临床严重程度(5.08 ± 1.03,P < 0.039)方面均有显著改善(P < 0.05)。在干预后 6 个月,实验组的疼痛点数、疼痛评分(8.25 ± 1.13,P < 0.048)、身体功能(58.60 ± 16.30,P < 0.049)和临床严重程度(5.28 ± 0.97,P < 0.043)的平均值明显较低。在干预后 1 年,只有第二左侧肋骨和左侧臀肌压痛点数、情感维度、感觉良好天数和临床严重程度有显著改善。
结果表明,肌筋膜松解技术可以作为纤维肌痛综合征疼痛症状、身体功能和临床严重程度的补充治疗方法,但不能改善患者的姿势稳定性。